BioStock: Emplicure's Chairman of the Board comments on the change of CEO

07 October 2022 - 08:47

Emplicure enters autumn with a new CEO and an approved application for a clinical pharmacokinetic study. BioStock talked to Chairman of the Board Gisela Sitbon about the company's eventful autumn and the reasoning behind the change of CEO.

Read the full article about Emplicure at

This is a press release from BioStock – Connecting Innovation & Capital.

Provided by: Cision
Nasdaq First North GM Stockholm (Sweden)
Emplicure AB
Emplicure is a pharmaceutical company that develops new innovative drugs based on the combination of already approved active substances and advanced materials science in bioceramics. The product portfolio initially focuses on drugs for chronic pain and with addictive properties....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More